Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists investigate why hepatitis b vaccine fails in some people

NCT ID NCT04674462

First seen Jan 08, 2026 · Last updated May 25, 2026 · Updated 24 times

Summary

This study looks at why some people have a weak response to the standard hepatitis B vaccine. Researchers will compare the standard vaccine with a newer one that works better for many people. The goal is to understand the immune system's response and help design more effective vaccines in the future. About 100 adults will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VACCINE REACTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • NYU Langone Health

    New York, New York, 10016, United States

Conditions

Explore the condition pages connected to this study.